This country profile provides an overview of the Central African Republic’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Central African Republic
- As a priority, the Central African Republic should submit the data on preventive chemotherapy (PC) coverage of bilharzia, river blindness and elephantiasis to WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage was 16% in 2016 and not reported in 2017.
Treatment coverage increased from 18% in 2016 to 32% in 2017.
Treatment coverage decreased from 40% in 2016 to 31% in 2017.
Treatment coverage was 66% in 2016 and not reported in 2017.
Treatment coverage was 50% in 2016 and not reported in 2017.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Central African Republic.